Investment update – Paraytec and Gyrometric

Summary by AI BETAClose X

Truetide plc has provided an investment update on its portfolio companies, Paraytec and Gyrometric. Paraytec, in which Truetide holds a 100% stake, has made a significant advancement in its CX300 instrument for detecting bacteria in blood, discovering small molecules that selectively bind to Gram-positive bacteria, a crucial step towards clinical application. Gyrometric Systems, where Truetide owns 21.43%, has successfully completed a US-UK project validating its patented technology for monitoring large journal bearings in wind turbines, addressing a critical gap in condition monitoring for these increasingly used components, with Gyrometric receiving nearly £300,000 from Innovate UK for its portion of the project.

Disclaimer*

UK 100

Latest directors dealings